Repligen Corporation
RGEN
$130.00
-$2.10-1.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.33% | -2.91% | -12.95% | -18.45% | -21.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.33% | -2.91% | -12.95% | -18.45% | -21.11% |
| Cost of Revenue | -2.40% | -7.43% | -6.90% | -8.05% | -6.45% |
| Gross Profit | 3.19% | 1.82% | -18.43% | -27.11% | -32.23% |
| SG&A Expenses | 9.86% | 20.96% | 12.10% | 1.78% | 0.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.36% | 2.98% | 0.21% | -4.34% | -3.73% |
| Operating Income | -23.69% | -58.75% | -79.04% | -74.31% | -74.82% |
| Income Before Tax | -147.67% | -87.54% | -81.96% | -76.59% | -74.12% |
| Income Tax Expenses | -107.20% | 205.30% | -16.13% | -25.14% | -36.38% |
| Earnings from Continuing Operations | -171.68% | -108.03% | -92.37% | -84.74% | -80.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -171.68% | -108.03% | -92.37% | -84.74% | -80.86% |
| EBIT | -23.69% | -58.75% | -79.04% | -74.31% | -74.82% |
| EBITDA | -5.94% | -24.09% | -47.99% | -49.18% | -53.80% |
| EPS Basic | -171.04% | -108.01% | -92.39% | -84.78% | -80.92% |
| Normalized Basic EPS | -36.27% | -51.90% | -69.06% | -63.52% | -62.88% |
| EPS Diluted | -173.93% | -108.31% | -92.47% | -84.73% | -80.75% |
| Normalized Diluted EPS | -35.53% | -50.89% | -68.34% | -62.92% | -62.06% |
| Average Basic Shares Outstanding | 0.39% | 0.40% | 0.41% | 0.45% | 0.47% |
| Average Diluted Shares Outstanding | -0.72% | -1.39% | -1.14% | -0.89% | -1.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |